Schwieger et al. [18] recently reported that the change from an ER or PgR+/HER2− at primary tumor to TNBC paired metastatic one was not associated with decreased survival (p > 0.05) in 258 analyzed patients. The gene discussed is ESR1; the disease is neoplasm.